SST and neoplasm: Sixty-nine percent of patients had not undergone any previous anti-tumor treatment, 31% had undergone a large variety of previous treatments, mainly consisting of somatostatin analogs, radioisotopes, chemotherapy, and targeted therapy (Supplementary Fig. 1d).